Answers are grounded in this paper and cite their sources.
Serum thyroxine (T 4 ) and triiodothyronine (T 3 ) concentrations by RIA were undetectable in a 14 year old hypothyroid girl who had goiter. Hormone dysgenesis was suspected in this patient and she was treated with T 4 . Although the clinical hypothyroid state improved towards normal, T 4 and T 3 values by RIA were consistently low. To clarify the discrepancy between laboratory and clinical diagnosis, T 4 concentration in serum was determined by non-RIA competitive protein displacement assay in the ethanol extract of the patient's serum. The value noted was 12.6 µg/100 ml and was consistent with the euthyroid state of T 4 treated patient. Prompted by these findings, the patient's serum was further subjected to serologic and electrophoretic analysis for screening anomalous T 4 binding proteins. A T 4 binding immunoglobulin in patient's serum was detected, while the serologic tests revealed a low thyroglobulin antibody titer. The antibody had high specificity for T 4 but not for T 3 and other thyroid analogues as noted in inhibition experiments. The electrophoretic observations demonstrating gamma globulinthyroxine interaction were consistent with that noted in an RIA system (using barbital and ANS) where antibody-tracer thyroxine binding curves were examined at various dilutions of patient's serum. The gradually increasing frequency of reports demonstrating gamma globulin interaction of thyroid hormone in thyroid diseases, stresses the need for setting up appropriate thyroid hormone assay controls to detect anomalous T 4 and T 3 binding proteins in serum in order to avoid erroneous laboratory and clinical diagnosis.
No takes yet. Share an insight, caveat, or question.
Herrmann et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: